Pebblebrook completes $44.25M sale of Montrose at Beverly Hills; another $72M hotel under contract

Pebblebrook Hotel Trust

Sale of 133-room Montrose at Beverly Hills for $44.25M to third party.
Sales price implies 16.1x EBITDA multiple and 5.2% NOI cap rate (4% capital reserve).
Proceeds to be used for debt reduction, share repurchases, and other capital allocation.
Transaction does not affect Q4 or full-year 2025 outlook issued Nov 5.
Company has one other hotel under contract at $72.0M, expected to close in Q4.

item 7.01 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001474098-25-000143
form_type: 8-K
ticker: PEB
cik: 0001474098
company_name: Pebblebrook Hotel Trust
filed_at: 2025-11-20T23:59:59+00:00
discovered_at: 2026-05-14T18:02:39.479919+00:00
generated_at: 2026-05-16T17:57:31.455650+00:00
sec_items: ["7.01", "8.01", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001474098-25-000143
json_url: https://secwatch.observer/filing/0001474098-25-000143.json
markdown_url: https://secwatch.observer/filing/0001474098-25-000143.md
text_url: https://secwatch.observer/filing/0001474098-25-000143.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1474098/000147409825000143/0001474098-25-000143-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1474098/000147409825000143/peb-20251119.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

NRXP

NRx Pharmaceuticals proposes public offering of common stock; terms not set

NRX Pharmaceuticals, Inc. June 2, 2026, 5:30 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

TOPP

Topppoint issues statement at NYSE request; no undisclosed material developments behind unusual trading

Toppoint Holdings Inc. June 2, 2026, 5:10 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

AVA

Avista signs non-binding MOU for 125 MW load, expandable to 500 MW by 2032

AVISTA CORP June 2, 2026, 5:02 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

SQFT

Presidio Property Trust annual meeting re-elects directors, approves incentive plan amendment; board reduced to five

Presidio Property Trust, Inc. June 2, 2026, 4:15 PM ET other_material Items 5.07, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

FNGR

FingerMotion evaluating AI-HPC and geographic expansion as part of strategic evolution

FingerMotion, Inc. June 2, 2026, 4:15 PM ET other_material Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

PEB

Pebblebrook Hotel Trust: Trustee Jackson retires; shareholders approve removal of trustee without cause

Pebblebrook Hotel Trust June 2, 2026, 4:15 PM ET other_material Items 5.02, 5.07, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

JAGX

Jaguar Health issues 64,668 common shares for Series Q Preferred; annual meeting adjourned to June 8

Jaguar Health, Inc. June 2, 2026, 4:10 PM ET other_material Items 1.01, 3.02, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

OTAI

Starlink AI Acquisition closes partial over-allotment, adds $5M to trust

Starlink AI Acquisition Corp June 2, 2026, 4:05 PM ET other_material Items 3.02, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001474098-25-000143

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.